Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -7.98 is 331% below its 5-year average of 3.46, near the low end of its 5-year range (-12.34–30.31).
3.45% above its 12-month average of -8.27.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.96.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-16T00:06:02.124Z. Historical observations retain their original dates. Historical series through 2023-11-03.
EARNINGS PER SHARE (EPS)
-7.98
EARNINGS PER SHARE (EPS) AVG TTM
-8.27
EARNINGS PER SHARE (EPS) AVG 3Y
-1.90
EARNINGS PER SHARE (EPS) AVG 5Y
3.46
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.45%
CURRENT VS 3Y AVG
-319.45%
CURRENT VS 5Y AVG
-330.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Moderna, Inc.
Market Cap
$57.05B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$54.49B
Earnings Per Share (EPS)
7.23
TTM Avg
6.88
3Y Avg
4.62
5Y Avg
2.87
Market Cap
$51.23B
Earnings Per Share (EPS)
3.32
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
Market Cap
$62.90B
Earnings Per Share (EPS)
13.46
TTM Avg
7.81
3Y Avg
8.10
5Y Avg
3.88
Market Cap
$49.37B
Earnings Per Share (EPS)
1.74
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
Market Cap
$65.21B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
Market Cap
$47.61B
Earnings Per Share (EPS)
10.56
TTM Avg
9.94
3Y Avg
15.54
5Y Avg
18.41
Market Cap
$45.71B
Earnings Per Share (EPS)
0.60
TTM Avg
-0.11
3Y Avg
-0.73
5Y Avg
-1.03
Market Cap
$44.39B
Earnings Per Share (EPS)
8.06
TTM Avg
7.74
3Y Avg
7.17
5Y Avg
5.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $57.05B | -7.98 | -8.27 | -1.90 | 3.46 |
| Cardinal Health, Inc. (CAH)vs › | $54.49B | 7.23 | 6.88 | 4.62 | 2.87 |
| Becton, Dickinson and Company (BDX)vs › | $51.23B | 3.32 | 5.86 | 5.65 | 5.38 |
| Cencora, Inc. (COR)vs › | $62.90B | 13.46 | 7.81 | 8.10 | 3.88 |
| Edwards Lifesciences Corporation (EW)vs › | $49.37B | 1.74 | 4.41 | 3.40 | 2.89 |
| Boston Scientific Corporation (BSX)vs › | $65.21B | 2.46 | 1.61 | 1.19 | 0.89 |
| Humana Inc. (HUM)vs › | $47.61B | 10.56 | 9.94 | 15.54 | 18.41 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.71B | 0.60 | -0.11 | -0.73 | -1.03 |
| IQVIA Holdings Inc. (IQV)vs › | $44.39B | 8.06 | 7.74 | 7.17 | 5.87 |
| Agilent Technologies, Inc. (A)vs › | $42.42B | 5.08 | 4.52 | 4.36 | 3.96 |
Trailing EPS (TTM)
$-7.98
Forward EPS (Est.)
$-8.31
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -7.26 |
| 2024-12-31 | -9.27 |
| 2023-12-31 | -12.34 |
| 2022-12-31 | 21.26 |
| 2021-12-31 | 30.31 |
| 2020-12-31 | -1.96 |
| 2019-12-31 | -1.55 |
| 2018-12-31 | -1.17 |
| 2017-12-31 | -0.72 |
| 2016-12-31 | -3.79 |
